ARCA Biopharma, a Westminster-based company specializing in targeted therapies for cardiovascular diseases, has reported the departure of their President and CEO, Dr. Michael Bristow, and appointment of Thomas Keuer as the new President. This transition took effect on April 3, 2024, when ARCA and Dr. Bristow mutually decided to end his tenure as both an…
This Article Is Locked, But Not Out of Reach
Jeffco BdB delivers smart insights on local businesses. Get a free account to unlock rankings, trends, and alerts tailored to you.
Curious how it works? Watch the Quickstart
Want everything unlocked? See Paid Options
Already a member? Log in here